|
gptkbp:instanceOf
|
gptkb:drug
benzodiazepine
|
|
gptkbp:approvedBy
|
1986
|
|
gptkbp:ATCCode
|
N05BE01
|
|
gptkbp:brand
|
gptkb:Buspar
|
|
gptkbp:CASNumber
|
36505-84-7
|
|
gptkbp:contraindication
|
hypersensitivity to buspirone
|
|
gptkbp:developedBy
|
gptkb:Bristol-Myers_Squibb
|
|
gptkbp:eliminationHalfLife
|
2-3 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:hasMolecularFormula
|
C21H31N5O2
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
buspirone
|
|
gptkbp:interactsWith
|
gptkb:beer
gptkb:milk
gptkb:rifampin
gptkb:MAO_inhibitors
gptkb:erythromycin
gptkb:ketoconazole
gptkb:verapamil
cimetidine
CYP3A4 inhibitors
diltiazem
other CNS depressants
|
|
gptkbp:IUPACName
|
gptkb:8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
|
|
gptkbp:KEGGID
|
gptkb:D00233
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
dopamine D2 receptor antagonist
serotonin 5-HT1A receptor partial agonist
|
|
gptkbp:MedlinePlusID
|
a688005
|
|
gptkbp:MeSH_ID
|
D002051
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
B (US)
B1 (Australia)
|
|
gptkbp:proteinBinding
|
95%
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL653
gptkb:DB00490
2440
2347
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:RxNormID
|
3108
|
|
gptkbp:sideEffect
|
nausea
dizziness
headache
excitement
nervousness
lightheadedness
|
|
gptkbp:synonym
|
gptkb:busp
gptkb:buspirone_hydrochloride
|
|
gptkbp:UNII
|
L7T10EIP3A
|
|
gptkbp:usedFor
|
gptkb:generalized_anxiety_disorder
anxiety
|
|
gptkbp:bfsParent
|
gptkb:generalized_anxiety_disorder
gptkb:CYP3A4_gene
gptkb:anxiety_disorder
|
|
gptkbp:bfsLayer
|
6
|